ArticlePulmonary therapy2025

A Retrospective Observational Study on COVID-19 Patients Receiving Treatment with Nirmatrelvir/Ritonavir (PAXLOVID).

Mariam M Murad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.